BPC157 TB500 | Lyophilized Laboratory Research Blend, 10 mg

TECHNICAL SPECIFICATIONS

• Components: Pentadecapeptide BPC-157 and thymosin beta-4 fragment.
• Total content: 10 mg.
• CAS registry numbers: 137525-51-0 (BPC-157) and 885340-08-9 (TB-500 fragment).
• Molecular weights: 1,419.56 Da (BPC-157) and 889.02 Da (TB-500 fragment).
• Molecular formulas: C₆₂H₉₈N₁₆O₂₂ (BPC-157) and C₃₈H₆₈N₁₀O₁₄ (TB-500 fragment).
• Purity: ≥99%, HPLC verified.
• Form: Co-lyophilized reagent blend.
• Storage: −20 °C, desiccated.
• BPC-157 sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

For laboratory research use only. Not for use in humans or animals.

ANALYTICAL RESEARCH CONTEXT

This co-lyophilized reagent combines BPC-157 and a thymosin beta-4-derived fragment for analytical laboratory work. Listed applications include instrument calibration, HPLC profiling, chemical stability assays, and solvent-interaction studies. Review lot documentation for suitability as an analytical reference.

The listed composition specifies a 1:1 molar ratio. Confirm component quantities and the ratio basis in the lot-specific documentation before interpreting analytical results.

COMPONENT IDENTITY AND PATHWAY REFERENCES

BPC-157 is discussed in nitric oxide synthase research and VEGF/VEGFR2-Akt-eNOS signaling, including EGR-1 expression and endothelial-cell readouts. These are pathway references for interpreting the component literature.

The TB-500 fragment is associated with actin-interaction research, including G-actin and F-actin relationships, cytoskeletal organization, cell-shape changes, and migration measurements. Fibroblast stress responses, migration, and extracellular-matrix readouts are described as experimental endpoints in the component literature. The blend format does not establish a synergistic interaction.

CHEMICAL STRUCTURES

BPC-157 Pentadecapeptide

BPC-157 is a synthetic 15-amino acid peptide based on a sequence identified in gastric material. CAS 137525-51-0; PubChem CID 9941957. The diagram provides structural context for the listed peptide sequence.

TB-500 Fragment, Ac-LKKTETQ

The thymosin beta-4-derived fragment Ac-LKKTETQ contains seven amino acids. CAS 885340-08-9; PubChem CID 16132341. The diagram provides structural context for actin-interaction research.

COMPONENT RESEARCH CONTEXT

MATERIAL FORMAT AND STORAGE

Co-lyophilization supplies both components within a predefined reagent composition, reducing variability associated with separate component measurements during laboratory preparation.

Inventory is stored at −20 °C and shipped with active cold packs. Temperature exposure is relevant to peptide integrity during transit and laboratory handling. Follow material documentation for storage and analytical evaluation.

LABORATORY SAFETY

Wear nitrile gloves and appropriate laboratory PPE. Refer to the Safety Data Sheet (SDS) for CAS 137525-51-0 and 885340-08-9. Follow institutional chemical-safety and disposal procedures.

Frequently Asked Questions

What analytical research context is described for this blend?

The co-lyophilized BPC-157 and TB-500 blend is supplied for analytical laboratory work, including chromatography profiling, chemical stability assays, and solvent-interaction studies. The component literature discusses VEGF and nitric oxide signaling for BPC-157 and actin dynamics for the TB-500 fragment. A combined format does not establish a synergistic effect.

Which TB-500 structure is referenced?

The referenced TB-500 structure is the thymosin beta-4-derived seven-amino acid fragment Ac-LKKTETQ, CAS 885340-08-9, PubChem CID 16132341. Full-length thymosin beta-4 contains 43 amino acids. The fragment provides structural context for actin-interaction research.

What laboratory safety and handling precautions apply?

Use nitrile gloves, eye protection, and a laboratory coat. Minimize aerosol generation and avoid inhalation and skin or eye contact when handling the lyophilized material or laboratory solutions. Refer to the SDS for CAS 137525-51-0 and 885340-08-9 and follow institutional chemical-safety procedures.

What solvent-system considerations apply to analytical assays?

Aqueous diluents and buffers provide solvent-system options for laboratory evaluation. BPC-157 is described as stable in acidic aqueous environments, and the TB-500 fragment is described as water-soluble. Select and evaluate the solvent system according to analytical requirements and material documentation.

For laboratory research use only. Not for use in humans or animals.